BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38448911)

  • 1. Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registry.
    Mendez GG; Nocek JM; Brambilla DJ; Jacobs S; Cole O; Kanter J; Glassberg J; Saving KL; Melvin CL; Gibson RW; Treadwell M; Jackson GL; King AA; Gordeuk VR; Kroner B; Hsu LL;
    BMC Health Serv Res; 2024 Mar; 24(1):291. PubMed ID: 38448911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What does it mean to be affiliated with care?: Delphi consensus on the definition of "unaffiliation" and "specialist" in sickle cell disease.
    Lamont AE; Hsu LL; Jacobs S; Gibson R; Treadwell M; Chen Y; Lottenberg R; Axelrod K; Varughese T; Melvin C; Smith S; Chukwudozie IB; Kanter J;
    PLoS One; 2022; 17(11):e0272204. PubMed ID: 36367870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care.
    Kanter J; Gibson R; Lawrence RH; Smeltzer MP; Pugh NL; Glassberg J; Masese RV; King AA; Calhoun C; Hankins JS; Treadwell M
    JAMA Netw Open; 2020 May; 3(5):e206016. PubMed ID: 32469413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives of individuals with sickle cell disease on barriers to care.
    Phillips S; Chen Y; Masese R; Noisette L; Jordan K; Jacobs S; Hsu LL; Melvin CL; Treadwell M; Shah N; Tanabe P; Kanter J
    PLoS One; 2022; 17(3):e0265342. PubMed ID: 35320302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective Recruitment Strategies for a Sickle Cell Patient Registry Across Sites from the Sickle Cell Disease Implementation Consortium (SCDIC).
    Masese RV; DeMartino T; Bonnabeau E; Burns EN; Preiss L; Varughese T; Nocek JM; Lasley P; Chen Y; Davila C; Nwosu C; Scott S; Bowman L; Gordon L; Clesca C; Peters-Lawrence M; Melvin C; Shah N; Tanabe P;
    J Immigr Minor Health; 2021 Aug; 23(4):725-732. PubMed ID: 33034793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell disease and social determinants of health: A scoping review.
    Khan H; Krull M; Hankins JS; Wang WC; Porter JS
    Pediatr Blood Cancer; 2023 Feb; 70(2):e30089. PubMed ID: 36495544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry.
    Glassberg JA; Linton EA; Burson K; Hendershot T; Telfair J; Kanter J; Gordeuk VR; King AA; Melvin CL; Shah N; Hankins JS; Epié AY; Richardson LD;
    Orphanet J Rare Dis; 2020 Jul; 15(1):178. PubMed ID: 32635939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specifying sickle cell disease interventions: a study protocol of the Sickle Cell Disease Implementation Consortium (SCDIC).
    Baumann AA; Belle SH; James A; King AA;
    BMC Health Serv Res; 2018 Jun; 18(1):500. PubMed ID: 29945631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in adults with sickle cell disease: Results from the sickle cell disease implementation consortium (SCDIC) registry.
    Njoku F; Pugh N; Brambilla D; Kroner B; Shah N; Treadwell M; Gibson R; Hsu LL; Gordeuk VR; Glassberg J; Hankins JS; Kutlar A; King AA; Kanter J
    Am J Hematol; 2024 May; 99(5):900-909. PubMed ID: 38450756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infertility and treatment-seeking practices among females and males with sickle cell disease in the Sickle Cell Disease Implementation Consortium registry.
    Stevenson E; Tanabe P; Knisely M; Masese R; Bulgin D; Preiss L; Hankins JS; King AA; Gordeuk V; Shah N
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30356. PubMed ID: 37057750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
    Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
    MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of medical conditions of children with sickle cell disease in the USA: findings from the 2007-2018 National Health Interview Survey (NHIS).
    Gyamfi J; Tampubolon S; Lee JT; Islam F; Ojo T; Opeyemi J; Qiao W; Mai A; Wang C; Vieira D; Ryan N; Osei-Tutu NH; Adenikinju D; Meda S; Ogedegbe G; Peprah E
    BMJ Open; 2023 Feb; 13(2):e069075. PubMed ID: 36854589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcomes in women with sickle cell disease in California.
    Adesina OO; Brunson A; Fisch SC; Yu B; Mahajan A; Willen SM; Keegan THM; Wun T
    Am J Hematol; 2023 Mar; 98(3):440-448. PubMed ID: 36594168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the 2007-2018 National Health Interview Survey (NHIS): Examining Neurological Complications among Children with Sickle Cell Disease in the United States.
    Peprah E; Gyamfi J; Lee JT; Islam F; Opeyemi J; Tampubolon S; Ojo T; Qiao W; Mai A; Wang C; Vieira D; Meda S; Adenikinju D; Osei-Tutu N; Ryan N; Ogedegbe G
    Int J Environ Res Public Health; 2023 Jun; 20(12):. PubMed ID: 37372724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Satisfaction and access to care for adults and adolescents with sickle cell disease: ASCQ-Me quality of care and the SHIP-HU study.
    Sisler I; McClish DK; Valrie C; Villella A; Smith WR
    Pediatr Blood Cancer; 2022 Dec; 69(12):e29948. PubMed ID: 36151945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of care in sickle cell disease: Cross-sectional study and development of a measure for adults reporting on ambulatory and emergency department care.
    Evensen CT; Treadwell MJ; Keller S; Levine R; Hassell KL; Werner EM; Smith WR
    Medicine (Baltimore); 2016 Aug; 95(35):e4528. PubMed ID: 27583862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal screening for social determinants of health in pediatric sickle cell disease: A quality-improvement initiative.
    Power-Hays A; Li S; Mensah A; Sobota A
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28006. PubMed ID: 31571379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium.
    Knisely MR; Pugh N; Kroner B; Masese R; Gordeuk V; King AA; Smith SM; Gurney JG; Adams R; Wun T; Snyder A; Glassberg J; Shah N; Treadwell M;
    Am J Hematol; 2020 Sep; 95(9):1066-1074. PubMed ID: 32449965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA.
    Smeltzer MP; Howell KE; Treadwell M; Preiss L; King AA; Glassberg JA; Tanabe P; Badawy SM; DiMartino L; Gibson R; Kanter J; Klesges LM; Hankins JS;
    BMJ Open; 2021 Nov; 11(11):e050880. PubMed ID: 34789492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Survey-Based Needs Assessment of Barriers to Optimal Sickle Cell Disease Care in the Emergency Department.
    Linton EA; Goodin DA; Hankins JS; Kanter J; Preiss L; Simon J; Souffront K; Tanabe P; Gibson R; Hsu LL; King A; Richardsona LD; Glassberg JA;
    Ann Emerg Med; 2020 Sep; 76(3S):S64-S72. PubMed ID: 32928465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.